Plant Summary

  Plant Information

TCMBank_ID:

TCMBANKHE008311
TCMBANKHE005739
TCMBANKHE006082
TCMBANKHE006193
TCMBANKHE007159

YEM_ID:

YEM-637

ID:

TCMBANKHE008311/YEM-637
TCMBANKHE005739/YEM-637
TCMBANKHE006082/YEM-637
TCMBANKHE006193/YEM-637
TCMBANKHE007159/YEM-637

植物拉丁名:

Vicia faba|Vicia faba L.
显示图片
Vicia faba var. equina|Vicia faba L.
显示图片

功能与主治:

To stanch bleeding, close sores./Hemoptysis, nosebleed(epistaxis), hematuria, bleeding of digestive tract, heaven-borne sore, scalds.
To fortify spleen and disinhibit water, resolve toxin and disperse swelling./Diaphragm food, edema, sore toxin.
To stanch bleeding, check diarrhea, resolve toxin and close sores./Internal bleeding, water diarrhea, scalds.
To stanch bleeding, close sores./Tuberculosis and hemoptysis, bleeding of digestive tract, bleeding due to external injury, shank sore.

药用植物名:

蚕豆荚壳|蚕豆
蚕豆
蚕豆茎|蚕豆
蚕豆叶|蚕豆
麻蚕豆|蚕豆

药名:

蚕豆

来源:

云南民族药物志：第四卷

药用部位:

pericarp
seed
stem
leaf

使用民族:

傣族/佤族/彝族

TCM_ID_id:

6506
3692
5818
6714
2429

   植物对应的化合物
化合物ID 化合物名 别名 分子式 分子质量 Smiles
TCMBANKIN002730 d-glyceric acid d-glycericacid C3H6O4 106.08 g/mol C(C(C(=O)O)O)O
TCMBANKIN058156 dopa 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphate (sodium salt); SODIUM (2R)-1-(HYDROGEN PHOSPHONATOOXY)-3-[(9Z)-OCTADEC-9-ENOYLOXY]PROPAN-2-YL (9Z)-OCTADEC-9-ENOATE; SCHEMBL940484; 1,2-Dioleoyl-sn-glycero-3-phosphoric acid monosodium salt, >=98% (TLC); sodium (2R)-2,3-bis[(9Z)-octadec-9-enoyloxy]propyl hydrogen phosphate; DTXSID1039686; 116004-31-0; 1,2-dioleoyl-sn-glycero-3-phosphate (sodium salt); 18:1 PA; 1-O,2-O-Dioleoyl-L-glycerin-3-phosphoric acid sodium salt;NCGC00093869-04; Alanine, 3-(3,4-dihydroxyphenyl)-, D- (8CI); NCGC00093869-03; D-Tyrosine, 3-hydroxy- (9CI); 3-(3,4-Dihydroxyphenyl)-D-alanine; 37840_FLUKA; D-3-Hydroxytyrosine; NSC 118368; (2R)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid; (2R)-2-amino-3-(3,4-dihydroxyphenyl)propionic acid; EINECS 227-343-0; 3-Hydroxy-D-tyrosine; D9378_SIGMA;Dopa D-form C9H11NO4 197.19 g/mol C1=CC(=C(C=C1CC(C(=O)O)N)O)O
TCMBANKIN061073 glyceride-1,3-dipalmito-2-sorbate C41H74O6 663 g/mol CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)C=CC=CC
TCMBANKIN002730 d-glyceric acid d-glycericacid C3H6O4 106.08 g/mol C(C(C(=O)O)O)O
TCMBANKIN004482 wyerone acid C14H12O4 244.24 g/mol CCC=CC#CC(=O)C1=CC=C(O1)C=CC(=O)O
TCMBANKIN021666 Wyerone 20079-30-5; methyl (2E)-3-{5-[(4Z)-hept-4-en-2-ynoyl]-2-furyl}acrylate; 3-(5-hept-4-en-2-ynoyl-furan-2-yl)-acrylic acid methyl ester; InChI=1/C15H14O4/c1-3-4-5-6-7-13(16)14-10-8-12(19-14)9-11-15(17)18-2/h4-5,8-11H,3H2,1-2H3/b5-4-,11-9; wyerone; methyl (E)-3-[5-[(Z)-hept-4-en-2-ynoyl]furan-2-yl]prop-2-enoate; C08465; (E)-3-[5-[(Z)-hept-4-en-2-ynoyl]-2-furyl]acrylic acid methyl ester; methyl (E)-3-[5-[(Z)-hept-4-en-2-ynoyl]-2-furyl]prop-2-enoate; (E)-3-[5-[(Z)-1-oxohept-4-en-2-ynyl]-2-furyl]prop-2-enoic acid methyl ester; 2-propenoic acid, 3-[5-[(4Z)-1-oxo-4-hepten-2-ynyl]-2-furanyl]-, methyl ester, (2E)- C15H14O4 258.27 CCC=CC#CC(=O)C1=CC=C(O1)C=CC(=O)OC
TCMBANKIN027920 pipecolic acid pipecolic acid ; pipecolicacid C6H11NO2 129.16 g/mol C1CCNC(C1)C(=O)O
TCMBANKIN032645 vicine C10H16N4O7 304.26 g/mol C(C1C(C(C(C(O1)OC2=C(N=C(NC2=O)N)N)O)O)O)O
TCMBANKIN032830 vignafuran C16H14O4 270.28 g/mol COC1=CC2=C(C=C1)C=C(O2)C3=C(C=C(C=C3)O)OC
TCMBANKIN050307 d-alpha-pipecoline d-α-pipecoline C6H13N 99.17 g/mol CC1CCCCN1
TCMBANKIN058156 dopa 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphate (sodium salt); SODIUM (2R)-1-(HYDROGEN PHOSPHONATOOXY)-3-[(9Z)-OCTADEC-9-ENOYLOXY]PROPAN-2-YL (9Z)-OCTADEC-9-ENOATE; SCHEMBL940484; 1,2-Dioleoyl-sn-glycero-3-phosphoric acid monosodium salt, >=98% (TLC); sodium (2R)-2,3-bis[(9Z)-octadec-9-enoyloxy]propyl hydrogen phosphate; DTXSID1039686; 116004-31-0; 1,2-dioleoyl-sn-glycero-3-phosphate (sodium salt); 18:1 PA; 1-O,2-O-Dioleoyl-L-glycerin-3-phosphoric acid sodium salt;NCGC00093869-04; Alanine, 3-(3,4-dihydroxyphenyl)-, D- (8CI); NCGC00093869-03; D-Tyrosine, 3-hydroxy- (9CI); 3-(3,4-Dihydroxyphenyl)-D-alanine; 37840_FLUKA; D-3-Hydroxytyrosine; NSC 118368; (2R)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid; (2R)-2-amino-3-(3,4-dihydroxyphenyl)propionic acid; EINECS 227-343-0; 3-Hydroxy-D-tyrosine; D9378_SIGMA;Dopa D-form C9H11NO4 197.19 g/mol C1=CC(=C(C=C1CC(C(=O)O)N)O)O
TCMBANKIN058162 LDP nchembio801-comp8; SPBio_001205; Spectrum3_000406; 51-61-6; cMAP_000036; KBio2_006628; Spectrum5_000945; DOPAMINE; KBio3_002867; 3-Hydroxtyramine; KBio3_002962; nchembio705-8; 4-(2-Aminoethyl)benzene-1,2-diol; 3, 4-Dihydroxyphenethylamine hydrochloride; 4-(2-aminoethyl)-pyrocatechol; 62-31-7 (HYDROCHLORIDE); Pyrocatechol, 4-(2-aminoethyl)-; Intropin {[as} hydrochloride]; NSC 173182; 4-(2-Aminoethyl)-1,2-bezenediol; KBioSS_001492; EINECS 200-110-0; cMAP_000065; Lopac-H-8502; KBio2_005052; KBioSS_002393; Dophamine; KBio2_004060; HSDB 3068; L-DOPAMINE; 4-(2-Aminoethyl)pyrocatechol; KW-3-060; BSPBio_001932; AIDS156129; KBioGR_002484; NCGC00096050-02; 3,4-Dihydroxyphenylethylamine; KBio2_004956; Spectrum2_001023; NSC169105 (HYDROCHLORIDE); Spectrum4_000525; (3H)-Dopamine; KBioGR_001129; 3-Hydroxytyramine; C03758; Dopamin; KBio2_007620; Dopaminum [INN-Latin]; m-Hydroxytyramine-; BPBio1_001123; Pyrocatechol, 4-(2-aminoethyl)- (8CI); alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane; KBioGR_002388; Biomol-NT_000001; 2-(3,4-dihydroxyphenyl)ethylamine; Lopac0_000586; Hydroxytyramin; DivK1c_000780; 4-(2-Aminoethyl)catechol; 4-(2-Aminoethyl)-1,2-benzenediol; CHEBI:18243; 3,4-dihydroxyphenethylamine; 1,2-Benzenediol, 4-(2-aminoethyl)- (9CI); IDI1_000780; NCGC00015519-01; NSC173182; 1,2-Benzenediol, 4-(2-aminoethyl)-; 50444-17-2; Oprea1_088821; hydroxytyramine; SBB004044; NCGC00096050-01; .alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane; Spectrum_001012; Dopamine (USAN)(*hydrochloride*); KBio2_002388; KBio3_001152; nchembio.78-comp16; Oxytyramine; KBio2_001492; KBioSS_002491; KBio1_000780; AIDS-156129; KBio2_002484; NINDS_000780; NCGC00096050-04; 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium; Dopamina [INN-Spanish]; KBio2_007524; SPECTRUM1505155; a-(3,4-Dihydroxyphenyl)-b-aminoethane; dopamine C8H11NO2 153.18 g/mol C1=CC(=C(C=C1CCN)O)O
TCMBANKIN058706 betulin AKOS025402304; Ambotz473-98-3; betulin ; AC-7983; SCHEMBL9888462; (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-ol; FVWJYYTZTCVBKE-MAIYTPNSSA-N; ; Trochol; 18211-63-7; C08618; Messagenin; 473-98-3; AIDS002710; B9757_SIGMA; ZINC03978650; Prestwick3_000990; Betulin; MEGxp0_001726; AI3-62999; BSPBio_001059; Lup-20(30)-ene-3beta,28-diol; C08631; Betulinol; ACon1_000091; AIDS-002710; Lup-20(29)-ene-3beta,28-diol; BPBio1_001165; Betuline; Lup-20(29)-ene-3,28-diol, (3beta)-; NSC 4644; (3.beta.)-Lup-20(29)-ene-3,28-diol; NSC692218; EINECS 207-475-5; Betulinic alcohol; ST5411404; Trochol C30H50O2 442.7g/mol CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)CO
TCMBANKIN059394 jatamansin MolPort-003-665-745; 19427-82-8; HMS2193F07; AmbscZ-048430; BRD-K07212038-001-02-1; MLS002472947; Jatamansin; SCHEMBL12062120; [(9R)-8,8-dimethyl-2-oxo-9,10-dihydropyrano[2,3-h]chromen-9-yl] (Z)-2-methylbut-2-enoate; Selinidin; SPECTRUM1504159; CHEMBL457257; ZINC28040; Xanthogalin; SDCCGMLS-0066791.P001; AC1LDJE7; BDBM50069685; SMR001397055; BSPBio_003337; J3.496.931K; Spectrum5_000398; (Z)-2-Methyl-2-butenoic acid (9R)-8,8-dimethyl-2-oxo-9,10-dihydro-2H,8H-benzo[1,2-b:3,4-b']dipyran-9-yl ester C19H20O5 328.4 g/mol CC=C(C)C(=O)OC1CC2=C(C=CC3=C2OC(=O)C=C3)OC1(C)C
TCMBANKIN060712 jasmonic acid C12H18O3 210.27 g/mol CCC=CCC1C(CCC1=O)CC(=O)O
TCMBANKIN061073 glyceride-1,3-dipalmito-2-sorbate C41H74O6 663 g/mol CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)C=CC=CC
TCMBANKIN061465 papaveraldine xanthaline C20H19NO5 353.37 g/mol COC1=C(C=C(C=C1)C(=O)C2=NC=CC3=CC(=C(C=C32)OC)OC)OC
TCMBANKIN002730 d-glyceric acid d-glycericacid C3H6O4 106.08 g/mol C(C(C(=O)O)O)O
TCMBANKIN061073 glyceride-1,3-dipalmito-2-sorbate C41H74O6 663 g/mol CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)C=CC=CC
TCMBANKIN002730 d-glyceric acid d-glycericacid C3H6O4 106.08 g/mol C(C(C(=O)O)O)O
TCMBANKIN012460 Folinic acid 4-{[(2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl)methyl]amino}-N-(1,3-dicobaltiopropyl)benzamide; folinic acid; N5 -Formyl-5,6,7,8- tetrahydropteroyl-L -glutamic acid; N5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid; folinicacid C99H148N24O24S2 2122.51 C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)[O-].O.O.O.O.O.[Ca+2]
TCMBANKIN019277 platanoside C39H32O14 724.7 g/mol CC1C(C(C(C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC=C(C=C4)O)OC(=O)C=CC5=CC=C(C=C5)O)OC(=O)C=CC6=CC=C(C=C6)O)O
TCMBANKIN032049 plastoquinone C53H80O2 749.2 g/mol CC1=C(C(=O)C(=CC1=O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C
TCMBANKIN037921 kaempferol-3-beta-d-gluco-7-alpha-l-rhamnoside kaempferol-3-β-d-gluco-7-α-l-rhamnoside C27H30O15
TCMBANKIN043354 Kaempferol-3-beta-D-goucuronide C21H18O12 462.36 c1([H])c(O[H])c(C(=O)C(O[C@@]2([H])[C@]([H])(O[H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C(=O)O[H])O2)=C(c3c([H])c([H])c(O[H])c([H])c3[H])O4)c4c([H])c1O[H]
TCMBANKIN047293 foliosidine COMTYGQAMQKQCJ-UHFFFAOYSA-N; 8-(2,3-Dihydroxy-3-methoxybutoxy)-4-methoxy-1-methylquinolin-2(1H)-one; 2520-38-9; 8-(2,3-DIHYDROXY-3-METHOXYBUTOXY)-4-METHOXY-1-METHYLQUINOLIN-2-ONE; CHEMBL1257061; DTXSID70585157; ACM2520389 C16H21NO5 307.34 g/mol CC(C)(C(COC1=CC=CC2=C1N(C(=O)C=C2OC)C)O)O
TCMBANKIN058156 dopa 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphate (sodium salt); SODIUM (2R)-1-(HYDROGEN PHOSPHONATOOXY)-3-[(9Z)-OCTADEC-9-ENOYLOXY]PROPAN-2-YL (9Z)-OCTADEC-9-ENOATE; SCHEMBL940484; 1,2-Dioleoyl-sn-glycero-3-phosphoric acid monosodium salt, >=98% (TLC); sodium (2R)-2,3-bis[(9Z)-octadec-9-enoyloxy]propyl hydrogen phosphate; DTXSID1039686; 116004-31-0; 1,2-dioleoyl-sn-glycero-3-phosphate (sodium salt); 18:1 PA; 1-O,2-O-Dioleoyl-L-glycerin-3-phosphoric acid sodium salt;NCGC00093869-04; Alanine, 3-(3,4-dihydroxyphenyl)-, D- (8CI); NCGC00093869-03; D-Tyrosine, 3-hydroxy- (9CI); 3-(3,4-Dihydroxyphenyl)-D-alanine; 37840_FLUKA; D-3-Hydroxytyrosine; NSC 118368; (2R)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid; (2R)-2-amino-3-(3,4-dihydroxyphenyl)propionic acid; EINECS 227-343-0; 3-Hydroxy-D-tyrosine; D9378_SIGMA;Dopa D-form C9H11NO4 197.19 g/mol C1=CC(=C(C=C1CC(C(=O)O)N)O)O
TCMBANKIN058162 LDP nchembio801-comp8; SPBio_001205; Spectrum3_000406; 51-61-6; cMAP_000036; KBio2_006628; Spectrum5_000945; DOPAMINE; KBio3_002867; 3-Hydroxtyramine; KBio3_002962; nchembio705-8; 4-(2-Aminoethyl)benzene-1,2-diol; 3, 4-Dihydroxyphenethylamine hydrochloride; 4-(2-aminoethyl)-pyrocatechol; 62-31-7 (HYDROCHLORIDE); Pyrocatechol, 4-(2-aminoethyl)-; Intropin {[as} hydrochloride]; NSC 173182; 4-(2-Aminoethyl)-1,2-bezenediol; KBioSS_001492; EINECS 200-110-0; cMAP_000065; Lopac-H-8502; KBio2_005052; KBioSS_002393; Dophamine; KBio2_004060; HSDB 3068; L-DOPAMINE; 4-(2-Aminoethyl)pyrocatechol; KW-3-060; BSPBio_001932; AIDS156129; KBioGR_002484; NCGC00096050-02; 3,4-Dihydroxyphenylethylamine; KBio2_004956; Spectrum2_001023; NSC169105 (HYDROCHLORIDE); Spectrum4_000525; (3H)-Dopamine; KBioGR_001129; 3-Hydroxytyramine; C03758; Dopamin; KBio2_007620; Dopaminum [INN-Latin]; m-Hydroxytyramine-; BPBio1_001123; Pyrocatechol, 4-(2-aminoethyl)- (8CI); alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane; KBioGR_002388; Biomol-NT_000001; 2-(3,4-dihydroxyphenyl)ethylamine; Lopac0_000586; Hydroxytyramin; DivK1c_000780; 4-(2-Aminoethyl)catechol; 4-(2-Aminoethyl)-1,2-benzenediol; CHEBI:18243; 3,4-dihydroxyphenethylamine; 1,2-Benzenediol, 4-(2-aminoethyl)- (9CI); IDI1_000780; NCGC00015519-01; NSC173182; 1,2-Benzenediol, 4-(2-aminoethyl)-; 50444-17-2; Oprea1_088821; hydroxytyramine; SBB004044; NCGC00096050-01; .alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane; Spectrum_001012; Dopamine (USAN)(*hydrochloride*); KBio2_002388; KBio3_001152; nchembio.78-comp16; Oxytyramine; KBio2_001492; KBioSS_002491; KBio1_000780; AIDS-156129; KBio2_002484; NINDS_000780; NCGC00096050-04; 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium; Dopamina [INN-Spanish]; KBio2_007524; SPECTRUM1505155; a-(3,4-Dihydroxyphenyl)-b-aminoethane; dopamine C8H11NO2 153.18 g/mol C1=CC(=C(C=C1CCN)O)O
TCMBANKIN061073 glyceride-1,3-dipalmito-2-sorbate C41H74O6 663 g/mol CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)C=CC=CC
TCMBANKIN032645 vicine C10H16N4O7 304.26 g/mol C(C1C(C(C(C(O1)OC2=C(N=C(NC2=O)N)N)O)O)O)O
TCMBANKIN032830 vignafuran C16H14O4 270.28 g/mol COC1=CC2=C(C=C1)C=C(O2)C3=C(C=C(C=C3)O)OC
   植物对应的疾病
疾病ID 病名 疾病类型 MeSH 参考文献
   植物对应的靶点
靶点ID 基因名 基因别名 描述 染色体位置 Map_Location 基因类型

Home | Browse | Search | Predict | Data | Contact | Help

Copyright © KUST | 滇ICP备16009434号-1 | Dai SX Lab